Professor Jason Lewis joins Clarity Pharmaceuticals’ Advisory Board
Sydney, Australia 11 October 2018 – Clarity Pharmaceuticals, an Australian radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Prof Jason S. Lewis has joined their scientific advisory board. Jason S. Lewis, PhD, serves as Vice Chair for Research in the Department of Radiology at Memorial Sloan Kettering Cancer Center (MSK),…